Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

21.28 +1.78 (+9.13%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
Meme Stocks GameStop, AMC Fade In Interest After Roaring Kitty Exit: Here's What WallStreetBets Is Eyeing Next ↗
Retail traders could be shifting away from meme stocks to several other stocks seeing strong interest on WallSteetBets. 
Via Benzinga
News headline image
XPeng Posts Strong Results, Joins Larimar Therapeutics, Transcat And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
What The Subtle Signs Say About The S&P 500 ↗
How to interpret the S&P 500’s behavior when testing previous all-time highs. 
Via Talk Markets
Topics Stocks
News headline image
Why Tandem Diabetes Stock Just Jumped 22% ↗
Tandem Diabetes stock is showing great growth -- but miserable profits. 
Via The Motley Fool
News headline image
S&P 500 Rises Over 1%; Hershey Earnings Top Views ↗
 
Via Benzinga
Topics Stocks
News headline image
Cracking The Code: Understanding Analyst Reviews For Tandem Diabetes Care ↗
 
Via Benzinga
News headline image
1 Beaten-Down Stock That Could Make You Richer ↗
Don't give up on this healthcare stock too soon. 
Via The Motley Fool
News headline image
Nasdaq Surges 2%; Apple Posts Upbeat Results ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Tandem Diabetes Catapults Above A Profit-Taking Zone, But DaVita Reverses, Nearly Triggering A Sell Signal ↗
Tandem Diabetes stock surged above a profit-taking zone on Friday, but DaVita reversed course and tumbled at the open. 
Via Investor's Business Daily
News headline image
Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Tandem Diabetes Care ↗
 
Via Benzinga
News headline image
Wall Street Looks To Feed Off Apple's Post-Earnings Power But Key Jobs Data May Upset The Cart: Analyst Says 'A Lot Of These Clouds Will Lift' If This Happens ↗
Stocks look set to carry forward the upward momentum on Friday amid some earnings cheer, although a tinge of nervousness is evident ahead of the all-important non-farm payrolls report. 
Via Benzinga
News headline image
TNDM Stock Earnings: Tandem Diabetes Care Beats EPS, Beats Revenue for Q1 2024 ↗
TNDM stock results show that Tandem Diabetes Care beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Tandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
TANDEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Tandem Diabetes Care, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
3 Weight-Loss ETFs to Profit From the Obesity Drug Boom ↗
Leverage Oprah's shift to prescription weight solutions with Weight-Loss ETFs, targeting companies leading in obesity treatment. 
Via InvestorPlace
Topics ETFs
News headline image
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
Why Tandem Diabetes Care Stock Was Zooming Higher Today ↗
One product in particular could juice the company's fundamentals, a pundit believes. 
Via The Motley Fool
News headline image
Stocks Inch Higher, Tesla Rebounds, Bitcoin Holds Below $70,000: What's Driving Markets Tuesday? ↗
Wall Street is set to break a two-day losing streak on Tuesday, as major indices trended positively during midday trading in New York. The S&P 500 saw a modest uptick of 0.3% for the day, with the Dow... 
Via Benzinga
Topics Stocks
News headline image
Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday. 
Via Benzinga
Topics Stocks
News headline image
Shhh! 7 Small-Cap Stocks That Can Double by 2025 ↗
Small-cap stocks have been hot and these shares discussed here are likely to heat up and double over the next year. 
Via InvestorPlace
News headline image
Parexel Announces CEO Succession Plan
Chief Operating & Growth Officer Peyton Howell to succeed Jamie Macdonald effective May 15, 2024; Mr. Macdonald to retire as CEO and continue on the Board of Directors through Dec. 31, 2024 
From Parexel International LLC
Via GlobeNewswire
News headline image
Tandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump Higher ↗
On Monday, Tandem Diabetes Care stock received an upgrade to its Relative Strength (RS) Rating, from 68 to 78. 
Via Investor's Business Daily
News headline image
Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.